{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:34:18Z","timestamp":1793370858849,"version":"4.5.0"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.fr","clinicalkey.jp","jprasopen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JPRAS Open"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jpra.2026.08.006","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T07:03:18Z","timestamp":1787122998000},"page":"111-120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Surgical management of plexiform neurofibromas: An imaging-based perioperative framework"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-3686-2968","authenticated-orcid":false,"given":"Kevin","family":"Ghajar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adham","family":"Elsherbini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Volfson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Yakubov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather L.","family":"Baltzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suganth","family":"Suppiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8499-701X","authenticated-orcid":false,"given":"Kevin J.","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.jpra.2026.08.006_bib0001","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1093\/neuonc\/noy067","article-title":"Association of plexiform neurofibroma volume changes and development of clinical morbidities in neurofibromatosis","volume":"20","author":"Gross","year":"2018","journal-title":"Neuro-Oncol"},{"key":"10.1016\/j.jpra.2026.08.006_bib0002","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.4","article-title":"Neurofibromatosis type 1","volume":"3","author":"Gutmann","year":"2017","journal-title":"Nat rev Dis primers"},{"issue":"1","key":"10.1016\/j.jpra.2026.08.006_bib0003","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/13543784.2022.2022120","article-title":"Plexiform neurofibroma: shedding light on the investigational agents in clinical trials","volume":"31","author":"Acar","year":"2022","journal-title":"Expert Opin Investig Drugs"},{"issue":"6","key":"10.1016\/j.jpra.2026.08.006_bib0004","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1002\/ajmg.a.62691","article-title":"Location, symptoms, and management of plexiform neurofibromas in 127 children with neurofibromatosis 1, attending the National Complex Neurofibromatosis 1 service, 2018-2019","volume":"188","author":"Collins-Sawaragi","year":"2022","journal-title":"Am J Med Genet A"},{"issue":"3","key":"10.1016\/j.jpra.2026.08.006_bib0005","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jpeds.2011.08.051","article-title":"Pediatric plexiform neurofibromas: impact on morbidity and mortality in neurofibromatosis type 1","volume":"160","author":"Prada","year":"2012","journal-title":"J Pediatr"},{"issue":"19","key":"10.1016\/j.jpra.2026.08.006_bib0006","doi-asserted-by":"crossref","first-page":"5695","DOI":"10.3390\/jcm11195695","article-title":"Surgical treatment and complications of deep-seated nodular plexiform neurofibromas associated with neurofibromatosis type 1","volume":"11","author":"Ikuta","year":"2022","journal-title":"J Clin Med"},{"issue":"11","key":"10.1016\/j.jpra.2026.08.006_bib0007","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1093\/neuonc\/noac146","article-title":"Management of neurofibromatosis type 1-associated plexiform neurofibromas","volume":"24","author":"Fisher","year":"2022","journal-title":"Neuro-Oncol"},{"issue":"3","key":"10.1016\/j.jpra.2026.08.006_bib0008","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3340\/jkns.2025.0041","article-title":"Treatment of plexiform neurofibromas: current perspectives on surgery and medical Treatment","volume":"68","author":"Hwang","year":"2025","journal-title":"J Korean Neurosurg Soc"},{"key":"10.1016\/j.jpra.2026.08.006_bib0009","first-page":"1","article-title":"The role of [18F]FDG-PET\/CT in predicting malignant transformation of plexiform neurofibromas in neurofibromatosis-1","volume":"2016","author":"Tovmassian","year":"2016","journal-title":"Int J Surg Oncol"},{"issue":"3","key":"10.1016\/j.jpra.2026.08.006_bib0010","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s11060-012-0840-5","article-title":"[18F]-Fluorodeoxyglucose positron emission tomography in children with neurofibromatosis type 1 and plexiform neurofibromas: correlation with malignant transformation","volume":"108","author":"Tsai","year":"2012","journal-title":"J Neurooncol"},{"issue":"2","key":"10.1016\/j.jpra.2026.08.006_bib0011","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1093\/annonc\/mdm450","article-title":"[18F]2-fluoro-2-deoxy-d-glucose positron emission tomography (FDG PET) as a diagnostic tool for neurofibromatosis 1 (NF1) associated malignant peripheral nerve sheath tumours (MPNSTs): a long-term clinical study","volume":"19","author":"Ferner","year":"2008","journal-title":"Ann Oncol: Off J Eur Soc Med Oncol"},{"key":"10.1016\/j.jpra.2026.08.006_bib0012","series-title":"Neurofibromatosis 1","author":"Friedman","year":"2025"},{"issue":"1","key":"10.1016\/j.jpra.2026.08.006_bib0013","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jcms.2004.08.004","article-title":"Subtotal and total resection of superficial plexiform neurofibromas of face and neck: four case reports","volume":"33","author":"Friedrich","year":"2005","journal-title":"J Cranio-Maxillo-Fac Surg: Off Publ Eur Assoc Cranio-Maxillo-Fac Surg"},{"issue":"9","key":"10.1016\/j.jpra.2026.08.006_bib0014","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1007\/s00234-003-0964-6","article-title":"Malignant peripheral nerve sheath tumours in neurofibromatosis type 1: MRI supports the diagnosis of malignant plexiform neurofibroma","volume":"45","author":"Mautner","year":"2003","journal-title":"Neuroradiology"},{"issue":"10","key":"10.1016\/j.jpra.2026.08.006_bib0015","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1093\/neuonc\/noac100","article-title":"Evaluation of magnetic resonance imaging-based radiomics characteristics for differentiation of benign and malignant peripheral nerve sheath tumors in neurofibromatosis type 1","volume":"24","author":"Ristow","year":"2022","journal-title":"Neuro-Oncol"},{"issue":"5","key":"10.1016\/j.jpra.2026.08.006_bib0016","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.3171\/2019.7.JNS191353","article-title":"Safe marginal resection of atypical neurofibromas in neurofibromatosis type 1","volume":"133","author":"Nelson","year":"2019","journal-title":"J Neurosurg"},{"issue":"7 Suppl 1","key":"10.1016\/j.jpra.2026.08.006_bib0017","first-page":"S111","article-title":"Imaging evaluation of plexiform neurofibromas in neurofibromatosis type 1: a survey-based assessment","volume":"97","author":"Ahlawat","year":"2021","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.jpra.2026.08.006_bib0018","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1007\/s00259-018-4227-5","article-title":"Comprehensive anatomical and functional imaging in patients with type I neurofibromatosis using simultaneous FDG-PET\/MRI","volume":"46","author":"Reinert","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.jpra.2026.08.006_bib0019","article-title":"Image-based differentiation of benign and malignant peripheral nerve sheath tumors in neurofibromatosis type 1","volume":"12","author":"Liu","year":"2022","journal-title":"Front Oncol"},{"issue":"3","key":"10.1016\/j.jpra.2026.08.006_bib0020","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1093\/neuros\/nyaa020","article-title":"Decision making in retroperitoneal nerve sheath and nerve-associated tumors: a modular approach","volume":"87","author":"Heinen","year":"2020","journal-title":"Neurosurgery"},{"issue":"6","key":"10.1016\/j.jpra.2026.08.006_bib0021","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1177\/17531934241238739","article-title":"An algorithmic approach to the management of peripheral nerve tumours","volume":"49","author":"Hems","year":"2024","journal-title":"J Hand Surg (Eur Vol)"},{"issue":"4","key":"10.1016\/j.jpra.2026.08.006_bib0022","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1227\/01.NEU.0000367636.91555.70","article-title":"The surgical management of symptomatic peripheral nerve sheath tumors","volume":"66","author":"Levi","year":"2010","journal-title":"Neurosurgery"},{"key":"10.1016\/j.jpra.2026.08.006_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101818","article-title":"ERN GENTURIS tumour surveillance guidelines for individuals with neurofibromatosis type 1","volume":"56","author":"Carton","year":"2023","journal-title":"EClinicalMedicine"},{"issue":"9","key":"10.1016\/j.jpra.2026.08.006_bib0024","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1093\/neuonc\/noaa053","article-title":"Longitudinal evaluation of peripheral nerve sheath tumors in neurofibromatosis type 1: growth analysis of plexiform neurofibromas and distinct nodular lesions","volume":"22","author":"Akshintala","year":"2020","journal-title":"Neuro-Oncol"},{"issue":"6","key":"10.1016\/j.jpra.2026.08.006_bib0025","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1093\/neuonc\/noy013","article-title":"The characteristics of 76 atypical neurofibromas as precursors to neurofibromatosis 1 associated malignant peripheral nerve sheath tumors","volume":"20","author":"Higham","year":"2018","journal-title":"Neuro-Oncol"},{"issue":"8","key":"10.1016\/j.jpra.2026.08.006_bib0026","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1093\/neuonc\/noz028","article-title":"Low mutation burden and frequent loss of CDKN2A\/B and SMARCA2, but not PRC2, define premalignant neurofibromatosis type 1-associated atypical neurofibromas","volume":"21","author":"Pemov","year":"2019","journal-title":"Neuro-Oncol"},{"issue":"9","key":"10.1016\/j.jpra.2026.08.006_bib0027","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1093\/neuonc\/noad053","article-title":"Atypical neurofibromas reveal distinct epigenetic features with proximity to benign peripheral nerve sheath tumor entities","volume":"25","author":"Kresbach","year":"2023","journal-title":"Neuro-Oncol"},{"issue":"1","key":"10.1016\/j.jpra.2026.08.006_bib0028","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26733","article-title":"Monitoring of plexiform neurofibroma in children and adolescents with neurofibromatosis type 1 by [18F]FDG-PET imaging. Is it of value in asymptomatic patients?","volume":"65","author":"Azizi","year":"2018","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"10.1016\/j.jpra.2026.08.006_bib0029","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00401-026-02979-7","article-title":"FAP expression as a marker of malignant transformation enabling in vivo characterization in peripheral nerve sheath tumors: a multimodal and translational study","volume":"151","author":"Reitsam","year":"2026","journal-title":"Acta Neuropathol"},{"issue":"12","key":"10.1016\/j.jpra.2026.08.006_bib0030","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1007\/s00268-021-06299-7","article-title":"Hemorrhagic complication in surgical resection for massive plexiform neurofibroma in body trunk: the flow-void sign as a predictor and preoperative embolization as prevention","volume":"45","author":"Michimoto","year":"2021","journal-title":"World J Surg"},{"issue":"6","key":"10.1016\/j.jpra.2026.08.006_bib0031","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1080\/02699052.2022.2077986","article-title":"Endovascular embolization of spontaneous massive hemorrhage of a facial plexiform neurofibroma: case report and literature review","volume":"36","author":"Jiang","year":"2022","journal-title":"Brain Inj"},{"key":"10.1016\/j.jpra.2026.08.006_bib0032","first-page":"1","article-title":"Multidisciplinary management of a giant plexiform neurofibroma by double sequential preoperative embolization and surgical resection","volume":"2013","author":"V\u00e9lez","year":"2013","journal-title":"Case Rep Neurol Med"},{"issue":"5","key":"10.1016\/j.jpra.2026.08.006_bib0033","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.jdcr.2020.02.023","article-title":"Surgery combined with embolization in the treatment of plexiform neurofibroma: case report and literature review","volume":"6","author":"Tovo Filho","year":"2020","journal-title":"JAAD Case Rep"},{"issue":"3","key":"10.1016\/j.jpra.2026.08.006_bib0034","doi-asserted-by":"crossref","first-page":"552","DOI":"10.3390\/jcm11030552","article-title":"Morphological relation of peripheral nerve sheath tumors and nerve fascicles: prospective study and classification","volume":"11","author":"Holzbauer","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.jpra.2026.08.006_bib0035","doi-asserted-by":"crossref","first-page":"e452","DOI":"10.1016\/j.wneu.2023.02.079","article-title":"Surgical management of lumbosacral plexus tumors","volume":"173","author":"Soldozy","year":"2023","journal-title":"World Neurosurg"},{"issue":"5","key":"10.1016\/j.jpra.2026.08.006_bib0036","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S0022-3476(97)70092-1","article-title":"Prognostic signs in the surgical management of plexiform neurofibroma: the Children's Hospital of Philadelphia experience, 1974-1994","volume":"131","author":"Needle","year":"1997","journal-title":"J Pediatr"},{"issue":"1","key":"10.1016\/j.jpra.2026.08.006_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.braindev.2024.10.008","article-title":"Clinical characteristics and management of plexiform neurofibromas in children with neurofibromatosis 1: a Japanese nationwide survey","volume":"47","author":"Sanefuji","year":"2025","journal-title":"Brain Dev"},{"issue":"10496","key":"10.1016\/j.jpra.2026.08.006_bib0038","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1016\/S0140-6736(25)00986-9","article-title":"Efficacy and safety of selumetinib in adults with neurofibromatosis type 1 and symptomatic, inoperable plexiform neurofibromas (KOMET)","volume":"405","author":"Chen","year":"2025","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.jpra.2026.08.006_bib0039","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/PRS.0000000000012302","article-title":"Cranial nerve ganglion involvement predicts malignant transformation of plexiform neurofibromas in neurofibromatosis type 1","volume":"157","author":"Gu","year":"2026","journal-title":"Plast Reconstr Surg"},{"issue":"6","key":"10.1016\/j.jpra.2026.08.006_bib0040","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.ijporl.2005.10.025","article-title":"Single stage near total resection of massive pediatric head and neck plexiform neurofibromas","volume":"70","author":"Ransom","year":"2006","journal-title":"Int J Pediatr Otorhinolaryngol"},{"issue":"7","key":"10.1016\/j.jpra.2026.08.006_bib0041","article-title":"Orbital\/Periorbital Plexiform neurofibromas: classification and surgical strategies for a better outcome. Plastic and reconstructive surgery","volume":"11","author":"Yoshinaga","year":"2023","journal-title":"Glob Open"},{"issue":"4","key":"10.1016\/j.jpra.2026.08.006_bib0042","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1055\/s-0034-1396793","article-title":"Massive plexiform neurofibroma of the neck and larynx","volume":"19","author":"Mobashir","year":"2015","journal-title":"Int Arch Otorhinolaryngol"},{"key":"10.1016\/j.jpra.2026.08.006_bib0043","article-title":"Esthetic unit-based surgical management of large facial plexiform neurofibromas","author":"Hoang","year":"2026","journal-title":"J Craniofac Surg"},{"issue":"3","key":"10.1016\/j.jpra.2026.08.006_bib0044","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jos.2025.10.007","article-title":"Circumferential parallel ligation for debulking of very large neurofibromas in patients with neurofibromatosis type 1","volume":"31","author":"Ariizumi","year":"2026","journal-title":"J Orthop Sci"},{"issue":"4","key":"10.1016\/j.jpra.2026.08.006_bib0045","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1097\/PRS.0b013e3181d180e9","article-title":"Facial aesthetic unit remodeling procedure for neurofibromatosis type 1 hemifacial hypertrophy: report on 33 consecutive adult patients","volume":"125","author":"Hivelin","year":"2010","journal-title":"Plast Reconstr Surg"},{"issue":"1","key":"10.1016\/j.jpra.2026.08.006_bib0046","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/SCS.0000000000010700","article-title":"Trapezius Island myocutaneous flap for head, neck, and facial reconstruction in neurofibromatosis type 1-associated plexiform neurofibromas","volume":"36","author":"Chen","year":"2025","journal-title":"J Craniofac Surg"},{"issue":"6","key":"10.1016\/j.jpra.2026.08.006_bib0047","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1097\/SCS.0000000000011771","article-title":"Multimodal intraoperative neurophysiological monitoring in neurofibromatosis type 1-related craniofacial tumor surgery","volume":"36","author":"Wu","year":"2025","journal-title":"J Craniofac Surg"},{"issue":"6","key":"10.1016\/j.jpra.2026.08.006_bib0048","doi-asserted-by":"crossref","first-page":"839","DOI":"10.3171\/2018.11.SPINE181095","article-title":"Diagnostic and therapeutic values of intraoperative electrophysiological neuromonitoring during resection of intradural extramedullary spinal tumors: a single-center retrospective cohort and meta-analysis","volume":"30","author":"Ishida","year":"2019","journal-title":"J Neurosurg Spine"},{"key":"10.1016\/j.jpra.2026.08.006_bib0049","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.wneu.2024.08.101","article-title":"Utility of sodium fluorescein during peripheral nerve tumor surgery: a scoping review of indications, techniques, and outcomes","volume":"191","author":"Asfour","year":"2024","journal-title":"World Neurosurg"},{"issue":"4","key":"10.1016\/j.jpra.2026.08.006_bib0050","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.ijom.2016.11.013","article-title":"Reconstruction with soft tissue free flaps for large defects after the resection of giant facial neurofibroma","volume":"46","author":"Hu","year":"2017","journal-title":"Int J Oral Maxillofac Surg"},{"issue":"4","key":"10.1016\/j.jpra.2026.08.006_bib0051","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/SAP.0b013e3182085b13","article-title":"Free flap reconstruction of extensive defects following resection of large neurofibromatosis","volume":"67","author":"Uygur","year":"2011","journal-title":"Ann Plast Surg"},{"issue":"5","key":"10.1016\/j.jpra.2026.08.006_bib0052","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1097\/SCS.0000000000009364","article-title":"Expansion technique for reconstruction of craniofacial defect after plexiform neurofibroma excision","volume":"34","author":"Ma","year":"2023","journal-title":"J Craniofac Surg"},{"issue":"7","key":"10.1016\/j.jpra.2026.08.006_bib0053","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.bjps.2011.11.034","article-title":"Craniofacial neurofibromatosis and tissue expansion: long-term results","volume":"65","author":"Singhal","year":"2012","journal-title":"J Plast Reconstr Aesthet Surg: JPRAS"},{"key":"10.1016\/j.jpra.2026.08.006_bib0054","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/1749-8090-6-119","article-title":"Surgical treatment of giant plexiform neurofibroma associated with pectus excavatum","volume":"6","author":"Ji","year":"2011","journal-title":"J Cardiothorac Surg"},{"issue":"2","key":"10.1016\/j.jpra.2026.08.006_bib0055","first-page":"35","article-title":"A study of 17 patients affected with plexiform neurofibromas in upper and lower extremities: comparison between different surgical techniques","volume":"51","author":"Onesti","year":"2009","journal-title":"Acta Chir Plast"},{"key":"10.1016\/j.jpra.2026.08.006_bib0056","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijscr.2015.01.015","article-title":"Hybrid resection of a giant thigh plexiform neurofibroma","volume":"8","author":"Kolker","year":"2015","journal-title":"Int J Surg Case Rep"},{"issue":"4","key":"10.1016\/j.jpra.2026.08.006_bib0057","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/neuonc\/noag023","article-title":"Neurofibromatosis type 1-plexiform neurofibromas: integrating treatment across pediatric and adult populations","volume":"28","author":"Armstrong","year":"2026","journal-title":"Neuro-Oncol"},{"issue":"1","key":"10.1016\/j.jpra.2026.08.006_bib0058","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1186\/s12885-023-10996-y","article-title":"Treatment decisions and the use of MEK inhibitors for children with neurofibromatosis type 1-related plexiform neurofibromas","volume":"23","author":"Armstrong","year":"2023","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.jpra.2026.08.006_bib0059","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1227\/00006123-198710000-00001","article-title":"Tumors of the brachial plexus","volume":"21","author":"Lusk","year":"1987","journal-title":"Neurosurgery"},{"issue":"4 Suppl 2","key":"10.1016\/j.jpra.2026.08.006_bib0060","first-page":"316","article-title":"Resection of a benign brachial plexus nerve sheath tumor using intraoperative electrophysiological monitoring","volume":"60","author":"Kwok","year":"2007","journal-title":"Neurosurgery"},{"issue":"4","key":"10.1016\/j.jpra.2026.08.006_bib0061","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1097\/JS9.0000000000000309","article-title":"Patient demographics, tumor characteristics, and outcomes following surgical treatment of benign and malignant brachial plexus tumors: a systematic review","volume":"109","author":"Shekouhi","year":"2023","journal-title":"Int J Surg"},{"issue":"6","key":"10.1016\/j.jpra.2026.08.006_bib0062","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1158\/1078-0432.CCR-25-2887","article-title":"SARC031: a phase II trial of Selumetinib and Sirolimus for patients with unresectable or metastatic malignant peripheral nerve sheath tumors (MPNST)","volume":"32","author":"Kim","year":"2026","journal-title":"Clin Cancer Res"},{"issue":"17","key":"10.1016\/j.jpra.2026.08.006_bib0063","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1158\/1078-0432.CCR-23-0749","article-title":"CDK4\/6-MEK inhibition in MPNSTs causes plasma cell infiltration, sensitization to PD-L1 blockade, and tumor regression","volume":"29","author":"Kohlmeyer","year":"2023","journal-title":"Clin Cancer Res"},{"issue":"5","key":"10.1016\/j.jpra.2026.08.006_bib0064","doi-asserted-by":"crossref","DOI":"10.1172\/JCI195652","article-title":"IFN signaling is associated with radiotherapy response in malignant peripheral nerve sheath tumors","volume":"136","author":"Zhu","year":"2026","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jpra.2026.08.006_bib0065","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.bjps.2023.04.054","article-title":"Resect, rewire, and restore: nerve transfer salvage of neurological deficits associated with soft tissue tumors","volume":"85","author":"Jawad","year":"2023","journal-title":"J Plast Reconstr Aesthet Surg: JPRAS"},{"issue":"1","key":"10.1016\/j.jpra.2026.08.006_bib0066","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/jso.26487","article-title":"Nerve transfers to restore femoral nerve function following oncologic nerve resection","volume":"124","author":"O\u2019Brien","year":"2021","journal-title":"J Surg Oncol"},{"issue":"5 Suppl","key":"10.1016\/j.jpra.2026.08.006_bib0067","first-page":"363","article-title":"Massive plexiform neurofibromas in childhood: natural history and management issues","volume":"106","author":"Serletis","year":"2007","journal-title":"J Neurosurg"},{"issue":"10","key":"10.1016\/j.jpra.2026.08.006_bib0068","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.3390\/jcm9103157","article-title":"Systemic treatment for advanced and metastatic malignant peripheral nerve sheath tumors","volume":"9","author":"Sobczuk","year":"2020","journal-title":"J Clin Med"},{"issue":"5","key":"10.1016\/j.jpra.2026.08.006_bib0069","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/jnci\/djaf359","article-title":"Malignant peripheral nerve sheath tumors: a report from Children\u2019s Oncology Group study ARST0332","volume":"118","author":"Crane","year":"2026","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jpra.2026.08.006_bib0070","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.881665","article-title":"Clinical outcome after pencil beam scanning proton therapy of patients with non-metastatic malignant and benign peripheral nerve sheath tumors","volume":"12","author":"Bachmann","year":"2022","journal-title":"Front Oncol"},{"issue":"5","key":"10.1016\/j.jpra.2026.08.006_bib0071","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s00701-016-2778-4","article-title":"Early postoperative haematomas in neurosurgery","volume":"158","author":"Nittby","year":"2016","journal-title":"Acta Neurochir"},{"issue":"3","key":"10.1016\/j.jpra.2026.08.006_bib0072","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1089\/sur.2011.126","article-title":"A multi-disciplinary review of the potential association between closed-suction drains and surgical site infection","volume":"14","author":"Reiffel","year":"2013","journal-title":"Surg Infect (Larchmt)"},{"issue":"5","key":"10.1016\/j.jpra.2026.08.006_bib0073","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.3171\/2022.7.JNS22691","article-title":"Postoperative surveillance in cranial and spinal tumor neurosurgery: when is this warranted?","volume":"138","author":"Schipmann","year":"2022","journal-title":"J Neurosurg"},{"issue":"3","key":"10.1016\/j.jpra.2026.08.006_bib0074","doi-asserted-by":"crossref","first-page":"655e","DOI":"10.1097\/PRS.0000000000009448","article-title":"Negative-pressure wound therapy versus standard surgical dressings after malignant tumor resection: a systematic review and meta-analysis","volume":"150","author":"Hays","year":"2022","journal-title":"Plast Reconstr Surg"},{"issue":"5","key":"10.1016\/j.jpra.2026.08.006_bib0075","doi-asserted-by":"crossref","first-page":"972e","DOI":"10.1097\/PRS.0000000000009023","article-title":"Closed-incision negative-pressure wound therapy after resection of soft-tissue tumors reduces wound complications: results of a randomized trial","volume":"149","author":"Dadras","year":"2022","journal-title":"Plast Reconstr Surg"},{"issue":"9","key":"10.1016\/j.jpra.2026.08.006_bib0076","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/gim.2013.30","article-title":"Growth behavior of plexiform neurofibromas after surgery","volume":"15","author":"Nguyen","year":"2013","journal-title":"Genet Med: Off J Am Coll Med Genet"},{"issue":"15","key":"10.1016\/j.jpra.2026.08.006_bib0077","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1056\/NEJMoa1912735","article-title":"Selumetinib in children with inoperable plexiform neurofibromas","volume":"382","author":"Gross","year":"2020","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jpra.2026.08.006_bib0078","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/s41591-024-03361-4","article-title":"Selumetinib in adults with NF1 and inoperable plexiform neurofibroma: a phase 2 trial","volume":"31","author":"Gross","year":"2025","journal-title":"Nat Med"},{"issue":"7","key":"10.1016\/j.jpra.2026.08.006_bib0079","doi-asserted-by":"crossref","first-page":"e1109","DOI":"10.1634\/theoncologist.2020-0069","article-title":"The use of MEK inhibitors in neurofibromatosis type 1-associated tumors and management of toxicities","volume":"25","author":"Klesse","year":"2020","journal-title":"Oncologist"},{"issue":"2","key":"10.1016\/j.jpra.2026.08.006_bib0080","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1007\/s10072-021-05361-5","article-title":"Epidemiological and clinical burden associated with plexiform neurofibromas in pediatric neurofibromatosis type-1 (NF-1): a systematic literature review","volume":"43","author":"Iheanacho","year":"2022","journal-title":"Neurol Sci: Off J Ital Neurol Soc Ital Soc Clin Neurophysiol"}],"container-title":["JPRAS Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352587826002937?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352587826002937?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:01:16Z","timestamp":1793368876000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352587826002937"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":80,"alternative-id":["S2352587826002937"],"URL":"https:\/\/doi.org\/10.1016\/j.jpra.2026.08.006","relation":{},"ISSN":["2352-5878"],"issn-type":[{"value":"2352-5878","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Surgical management of plexiform neurofibromas: An imaging-based perioperative framework","name":"articletitle","label":"Article Title"},{"value":"JPRAS Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpra.2026.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of British Association of Plastic, Reconstructive and Aesthetic Surgeons.","name":"copyright","label":"Copyright"}]}}